Botanix Pharmaceuticals Ltd has released a press release.
Botanix Commences First Clinical Study for BTX 1503
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Botanix Pharmaceuticals
- Completion of the Tranche 1 Placement
- Reinstatement to official quotation
- Suspension from Official Quotation
- Botanix Receives Approval for Synthetic Cannabidiol Trial
- Export and Import Approvals for Clinical Studies Received
Later from Botanix Pharmaceuticals
- Completion of Tranche 2 of Capital Raising Placement
- Successful Pilot Study for BTX 1701 Facial Cleanser
- 12 Month Operational Review Highlights Significant Progress
- Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
- Botanix Commences BTX 1503 Acne Patient Study
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals